FDA Compliance for Peptide Therapy and BPC 157 Holt Law FDA moves toward easing restrictions on certain peptides BioPharma Dive The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few